203 related articles for article (PubMed ID: 3048806)
1. Differential isotype recognition of two centromere associated polypeptides by immunoblotting in connective tissue disease.
McHugh NJ; James IE; Maddison PJ
Clin Exp Immunol; 1988 Jun; 72(3):457-64. PubMed ID: 3048806
[TBL] [Abstract][Full Text] [Related]
2. Human anti-centromere sera recognise a 19.5 kD non-histone chromosomal protein from HeLa cells.
Guldner HH; Lakomek HJ; Bautz FA
Clin Exp Immunol; 1984 Oct; 58(1):13-20. PubMed ID: 6383665
[TBL] [Abstract][Full Text] [Related]
3. The heterogeneity of anticentromere antibodies in immunoblotting analysis.
Muro Y; Sugimoto K; Okazaki T; Ohashi M
J Rheumatol; 1990 Aug; 17(8):1042-7. PubMed ID: 2213779
[TBL] [Abstract][Full Text] [Related]
4. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
Uchida K; Kondo H; Kashiwazaki S
Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895
[No Abstract] [Full Text] [Related]
5. Proteins responsible for anticentromere activity found in the sera of patients with CREST-associated Raynaud's phenomenon.
Kremer L; Alvaro-Gracia JM; Ossorio C; Avila J
Clin Exp Immunol; 1988 Jun; 72(3):465-9. PubMed ID: 3048807
[TBL] [Abstract][Full Text] [Related]
6. [Anticentromere antibodies. Diagnostic and prognostic value].
Meyer O; Haïm T
Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of antibodies to a 68 kDa U1RNP polypeptide in connective tissue disease.
McHugh N; James I; Maddison P
J Rheumatol; 1990 Oct; 17(10):1320-8. PubMed ID: 1701488
[TBL] [Abstract][Full Text] [Related]
8. [Significance of anti-centromere antibodies. Clinical value].
Meyer O; Haim T; Ryckewaert A
Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
[TBL] [Abstract][Full Text] [Related]
9. Anticentromere antibody and immunoglobulin allotypes in scleroderma.
Chen ZY; Fedrick JA; Pandey JP; Silver R; Maricq HR; Fudenberg HH; Dobson RL; Ainsworth SK
Arch Dermatol; 1985 Mar; 121(3):339-44. PubMed ID: 3883903
[TBL] [Abstract][Full Text] [Related]
10. A highly conserved 72,000 dalton centromeric antigen reactive with autoantibodies from patients with progressive systemic sclerosis.
McNeilage LJ; Whittingham S; McHugh N; Barnett AJ
J Immunol; 1986 Oct; 137(8):2541-7. PubMed ID: 3531335
[TBL] [Abstract][Full Text] [Related]
11. [The clinical spectrum of patients with anticentromere antibodies].
Insua Vilariño S; de la Hera Martínez M; Rodríguez-Valverde V; Merino Pérez J; Alonso Valdivieso JL; Ruiz T
Rev Clin Esp; 1993 Apr; 192(6):260-4. PubMed ID: 8497719
[TBL] [Abstract][Full Text] [Related]
12. Anticentromere autoantibodies in patients without Raynaud's disease or systemic sclerosis.
Vázquez-Abad D; Grodzicky T; Senécal JL
Clin Immunol; 1999 Feb; 90(2):182-9. PubMed ID: 10080829
[TBL] [Abstract][Full Text] [Related]
13. Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
Earnshaw W; Bordwell B; Marino C; Rothfield N
J Clin Invest; 1986 Feb; 77(2):426-30. PubMed ID: 3511098
[TBL] [Abstract][Full Text] [Related]
14. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
15. [Centromere antibodies and antibodies against Scl 70 nucleoprotein in progressive systemic scleroderma. Diagnostic and prognostic significance].
Meurer M; Scharf A; Luderschmidt C; Braun-Falco O
Dtsch Med Wochenschr; 1985 Jan; 110(1):8-14. PubMed ID: 3880700
[TBL] [Abstract][Full Text] [Related]
16. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of anticentromere antibody assay].
Moteki S
Nihon Rinsho; 1990 Feb; 48 Suppl():580-3. PubMed ID: 2192153
[No Abstract] [Full Text] [Related]
18. Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.
Giordano M; Valentini G; Migliaresi S; Picillo U; Vatti M
J Rheumatol; 1986 Oct; 13(5):911-6. PubMed ID: 3546686
[TBL] [Abstract][Full Text] [Related]
19. Anticentromere antibodies--clinical correlates.
Wade JP; Sack B; Schur PH
J Rheumatol; 1988 Dec; 15(12):1759-63. PubMed ID: 3265957
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of anticentromere antibodies in patients with systemic lupus erythematosus.
Nakano M; Ohuchi Y; Hasegawa H; Kuroda T; Ito S; Gejyo F
J Rheumatol; 2000 Jun; 27(6):1403-7. PubMed ID: 10852261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]